POM-V Prescription Required Companion Animal

Intubeaze 20 mg/ml Laryngopharyngeal Spray, Solution for Cats

Active ingredient: Lidocaine Hydrochloride

Form

Spray

Species

Cats

Manufacturer

Dechra Regulatory B.V.

VMD MA No.

50406/3027

What it's used for

Local anaesthesia of the laryngeal mucosa of the cat in order to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Lidocaine Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Intubeaze 20 mg/ml Laryngopharyngeal Spray, Solution for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Local anaesthesia of the laryngeal mucosa of the cat in order to facilitate
endotracheal intubation by preventing the stimulation of the laryngeal reflex.

For laryngopharyngeral use.
Give one or two sprays at the back of the throat.
Prior to use, prime the pump until liquid is released. Minimum of 4 sprays are
recommended for priming the bottle before first use and at least 2 sprays are
recommended for re-priming if unused for 7 days or longer.

Revised: April 2025
AN: 04127/2024
Each spray (approximately 0.14 ml) contains approximately 2.8 mg of lidocaine
hydrochloride monohydrate, which corresponds to 2.27 mg of lidocaine.
Allow 30-90 seconds before attempting intubation, so that the larynx is relaxed.
It should be noted that when removing the actuator from the spray pump it should be
done vertically and not at an angle to ensure the pin does not get damaged.

Do not use in animals which are hypovolaemic or show heart block. Do not use in
known cases of hypersensitivity to the active substance or any of the excipients.

Revised: April 2025
AN: 04127/2024

None known.

Laryngeal spasm can also be stimulated by removal of the endotracheal tube. This
should be carried out while the patient is still under anaesthesia.

Special precautions for use in animals
Use with care in cases with hepatic and or cardiac insufficiency.
It is advisable to cold sterilise the nozzle between uses to avoid the spread of
infection.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
•
People with known hypersensitivity to these substances should avoid contact
with the product.
•
and systemic effects, such as dizziness or drowsiness. Accidental exposure,
particularly oral, eye and inhalation exposure, should be avoided.
•
If accidental exposure to eyes occurs, rinse with water.
•
label to the physician.
•
metabolites can also induce, in long-term toxicology studies in rats,
carcinogenic effects at high doses.

None known.

Do not store above 25 °C.

Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.